|
|
|
Insider
Information: |
Cui Xiangmin |
Relationship: |
|
City: |
Taian City, Shandong, Chi |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
4,958,810 |
|
Indirect Shares
|
16,975,077 |
|
|
Direct
Value |
$174,550,112 |
|
|
Indirect Value
|
$598,087,449 |
|
|
Total
Shares |
21,933,887 |
|
|
Total
Value |
$772,637,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
142.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Armo Biosciences Inc |
ARMO |
Director |
2018-01-30 |
0 |
2018-06-22 |
0 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Director, 10% Owner |
2019-01-18 |
0 |
2024-01-18 |
8,317,924 |
Premium* |
|
Equillium Inc |
EQ |
10% Owner |
|
0 |
2021-02-05 |
3,285,710 |
Premium* |
|
Cue Health Inc. |
HLTH |
|
2021-09-28 |
0 |
2021-09-28 |
788,441 |
Premium* |
|
CG Oncology, Inc |
CGON |
10% Owner |
2024-01-29 |
4,958,810 |
2024-01-29 |
400,000 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
|
2024-04-09 |
0 |
2024-04-09 |
4,183,002 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EQ |
Equillium Inc |
10% Owner |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,285,710 |
|
- |
|
CGON |
CG Oncology, Inc |
10% Owner |
|
2024-01-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
930,612 |
|
- |
|
ARMO |
Armo Biosciences Inc |
Director |
|
2018-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,214,700 |
1,214,700 |
0 |
- |
|
HLTH |
Cue Health Inc. |
|
|
2021-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
8,192,468 |
8,192,468 |
0 |
- |
|
CGON |
CG Oncology, Inc |
10% Owner |
|
2024-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,628,198 |
4,558,812 |
0 |
- |
|
NUVB |
Nuvation Bio Ord Shs Clas... |
|
|
2024-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
6,172,344 |
4,183,002 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Director |
|
2019-01-18 |
4 |
A |
$5.37 |
$16,999,997 |
I/I |
3,165,735 |
3,165,735 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Director |
|
2022-09-23 |
4 |
A |
$7.35 |
$14,700,000 |
I/I |
2,000,000 |
1,360,544 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Director |
|
2021-09-17 |
4 |
B |
$9.40 |
$14,499,998 |
I/I |
1,542,553 |
4,708,288 |
2.25 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Director |
|
2023-11-09 |
4 |
B |
$12.50 |
$4,687,500 |
I/I |
375,000 |
1,735,544 |
2.25 |
% |
|
ALPN |
Alpine Immune Sciences In... |
Director |
|
2024-01-18 |
4 |
OE |
$12.74 |
$15,729,263 |
I/I |
1,234,636 |
6,582,380 |
0 |
- |
|
HLTH |
Cue Health Inc. |
|
|
2021-09-28 |
4 |
A |
$12.80 |
$10,092,045 |
I/I |
788,441 |
788,441 |
0 |
- |
|
CGON |
CG Oncology, Inc |
10% Owner |
|
2024-01-29 |
4 |
B |
$19.00 |
$7,600,000 |
I/I |
400,000 |
400,000 |
1.5 |
% |
|
CGON |
CG Oncology, Inc |
10% Owner |
|
2024-01-29 |
4/A |
B |
$19.00 |
$7,600,000 |
D/D |
400,000 |
4,958,810 |
2.45 |
- |
|
ARMO |
Armo Biosciences Inc |
Director |
|
2018-06-22 |
4 |
D |
$50.00 |
$60,735,000 |
I/I |
(1,214,700) |
0 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|